Home/Direct Biologics/Tim Moseley, PhD
TM

Tim Moseley, PhD

Chief Scientific Officer

Direct Biologics

Direct Biologics Pipeline

DrugIndicationPhase
ExoFlo™All-Cause Acute Respiratory Distress Syndrome (ARDS)Phase 3